Eversept Partners, LP - GOSSAMER BIO INC ownership

GOSSAMER BIO INC's ticker is GOSS and the CUSIP is 38341P102. A total of 100 filers reported holding GOSSAMER BIO INC in Q2 2023. The put-call ratio across all filers is 3.74 and the average weighting 0.0%.

Quarter-by-quarter ownership
Eversept Partners, LP ownership history of GOSSAMER BIO INC
ValueSharesWeighting
Q3 2023$3,687,519
+309.9%
4,427,857
+490.6%
0.31%
+316.0%
Q2 2023$899,636
-47.2%
749,697
-44.6%
0.08%
-37.0%
Q1 2023$1,703,602
+409.1%
1,352,065
+776.8%
0.12%
+310.3%
Q4 2022$334,640
-94.9%
154,212
-71.9%
0.03%
-94.9%
Q3 2022$6,570,203
+67.6%
548,431
+17.1%
0.57%
+103.9%
Q2 2022$3,919,696
+20.5%
468,303
+25.0%
0.28%
+11.6%
Q1 2022$3,252,596
+620.6%
374,723
+838.9%
0.25%
+762.1%
Q4 2021$451,382
-76.0%
39,910
-73.4%
0.03%
-77.9%
Q3 2021$1,884,369149,9100.13%
Other shareholders
GOSSAMER BIO INC shareholders Q2 2023
NameSharesValueWeighting ↓
Octagon Capital Advisors LP 1,513,138$19,020,0004.68%
Omega Fund Management, LLC 3,320,608$41,740,0004.68%
Ally Bridge Group (NY) LLC 1,175,000$14,770,0004.34%
Parkman Healthcare Partners LLC 786,870$9,891,0002.50%
Palo Alto Investors LP 1,772,950$22,286,0001.34%
HHLR ADVISORS, LTD. 7,420,974$93,282,0001.22%
Ikarian Capital, LLC 1,351,933$16,995,0001.20%
Boxer Capital, LLC 2,462,358$30,952,0001.08%
ACUTA CAPITAL PARTNERS, LLC 215,000$2,703,0000.95%
EMERALD ADVISERS, LLC 1,516,003$19,056,0000.69%
View complete list of GOSSAMER BIO INC shareholders